United Kingdom · Question · Written question
UIN 15739
Medicines and Healthcare products Regulatory Agency: Fees and Charges
Introduced
25 November 2024
Last action
2 December 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Healthcare
Source updated
2 December 2024
Summary
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the proposed reform of Medicines and Healthcare products Regulatory Agency statutory fees on investment in the UK market by medical technolo
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 November 2024
Written question
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the proposed reform of Medicines and Healthcare products Regulatory Agency statutory fees on investment in the UK market by medical technolo
Source: Commons
2 December 2024
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices, and blood components for transfusion in the United Kingdom.Most of the MHRA’s income comes from charging fees for its services. Its fees are set to recove...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-11-25/15739
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1744095
- uk · wq-1744095 · source updated 2 December 2024